Best Grants for Cancer Nonprofits in Mississippi

Cancer research institutions conducting translational oncology studies that include a required clinical trial can seek funding to advance prevention, early detection, diagnosis, and treatment of human cancers. National Cancer Institute SPORE P50 center grants support organ-specific or biologically related cancer research, and Mississippi cancer organizations partnered with eligible research centers may benefit from this opportunity.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. The Heart of Illinois Community Foundation scholarship may benefit cancer-focused organizations in Mississippi through staff who meet the Illinois residency and service criteria.

Full-time clinician faculty in radiation oncology conducting cancer research in Mississippi can apply for the ASTRO-ACS Clinician Scientist Development Grant, receiving US $135,000 per year for 3–5 years. Focused on cancer/oncology, American Society for Radiation Oncology invites eligible U.S. academic or nonprofit-based investigators to advance independent clinician-scientist careers.

Practicing radiation oncologists in the U.S., including those serving Mississippi patients, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for cancer research. This American Society for Radiation Oncology partnership supports projects addressing questions across the cancer care continuum.

Mississippi cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible 501(c)(3) organizations can access funding through Incyte for healthcare education and information initiatives. Grants, charitable contributions, and sponsorships support programs that improve access to cancer and disease-related information for students, healthcare providers, patients, and caregivers, consistent with Incyte’s medical education and patient care priorities.

Cancer-focused medical schools, hospitals, patient advocacy groups, and 501(c)(3) nonprofits in Mississippi can seek funding for healthcare information and education initiatives. Focused on cancer and other serious diseases, Incyte supports programs that help students, healthcare providers, patients, and caregivers access critical healthcare information through charitable contributions, sponsorships, and memberships.

Cancer research institutions and oncology-focused organizations in Mississippi and beyond can seek funding to study how best to combine radiation therapy and immunotherapy to improve patient outcomes. With a mission to advance innovative cancer treatment research, Radiation Oncology Institute provides awards of US $50,000 - US $100,000 for projects on treatment optimization, toxicity reduction, education, and access to care.

Cancer research institutions and oncology teams in Mississippi and beyond can seek funding to study combination radiation therapy and immunotherapy approaches. With a mission to advance radiation oncology, American Society For Radiation Oncology provides support through the Radiation Oncology Institute Innovation Awards, offering up to US $100,000 for bold, practice-changing cancer research projects.

Mississippi cancer and oncology organizations educating healthcare professionals on muscle invasive bladder cancer can access funding through Pfizer for independent medical education initiatives. Grants from US $10,000 - US $220,000 support projects that address unmet needs, highlight emerging MIBC data, and improve knowledge and practice among clinicians treating bladder cancer, within Pfizer and Astellas’s global program.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The ASCO Clinical Oncology & Research Experience (ASCO CORE) offers medical students immersive exposure to the field of oncology through shadowing experiences in clinical and research settings. With two distinct tracks, participants can gain insights into patient care or research practices, guided by mentors. Eligible students must be enrolled in a U.S. DO or MD program and maintain a good academic record. This program aims to inspire the next generation of oncology professionals.

Grants Program for Penn Investigators - Faculty Awards

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Faculty Awards

Faculty awards are for two years with a funding level up to $200,000 per year.

Grants Program for Penn Investigators - Early career awards for Fellows, Postdocs and Instructors

Research grant applications in basic science, prevention, disease interception, and early detection that are relevant to the study of BRCA1/2 will be considered. The Basser Cancer Interception Institute focuses on funding new endeavors in emerging, orthogonal fields beyond DNA damage (e.g. mechanisms of haploinsufficiency, cancer evolution and tissue tropism). 

Grants focused on the following are of particular interest:

• Cancer interception and the pre-cancer disease state
• Issues relevant to men (including but not limited to prostate cancer, pancreatic cancer, male breast cancer)
• Potential for translation into clinical practice
• Early detection

Grants that demonstrate a potential for translation into clinical practice will be prioritized for funding.

Early career awards for Fellows, Postdocs and Instructors

Early career awards for Fellows, Postdocs and Instructors up to $100,000 for one year. Grants are eligible for competitive renewal upon reapplication and are contingent on progress the first year.

The CORE Funding: AHNS Presidential Award supports innovative research that integrates emerging technologies in head and neck cancer studies. This initiative aims to address critical gaps in early detection and treatment, especially for patients with advanced disease. By leveraging tools such as AI and advanced imaging, the program seeks to enhance understanding of disease mechanisms and improve patient-centered intervention strategies, ultimately advancing the field of otolaryngology.

The CORE Funding: AHNS Thyroid Cancer Survivors’ Association Award aims to support vital research projects focused on thyroid cancer, encompassing prevention, diagnosis, treatment, and outcomes. This initiative by the American Academy of Otolaryngology - Head and Neck Surgery Foundation promotes advancements in the field through funding opportunities that enhance research capabilities and foster collaboration among researchers. Through the support of this award, significant strides can be made in understanding and combating thyroid cancer.

The CORE Funding: AHNS Trainee Pilot Research Award supports innovative research in head and neck oncology, encouraging trainees to engage in clinical or translational studies. Since its inception, CORE has provided over $14 million in grants, facilitating significant advancements in otolaryngology. This initiative aims to enhance research efforts, reduce fragmentation, and promote collaboration among various stakeholders to improve outcomes for patients with head and neck neoplastic diseases.

The CORE Funding: Lilly Research Grant aims to advance research on genetic hearing loss. It invites investigators to explore the genetic factors contributing to hearing loss, promoting innovative projects that enhance understanding in this critical area. Supported by the American Academy of Otolaryngology - Head & Neck Surgery Foundation, the grant fosters significant research efforts to improve outcomes and strategies in otolaryngology, ensuring a comprehensive approach to hearing health.

About Pfizer External Research & Grants

Pfizer External Research & Grants (ER&G) supports independent research, education, and QI initiatives to improve patient outcomes in areas of unmet need. Competitive grants are awarded through transparent RFPs reviewed by independent expert panels.

About ASCP

American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organization for pathologists and laboratory professionals, with more than 100,000 members. ASCP provides excellence in education, certification, and advocacy on behalf of patients and the laboratory workforce. With a portfolio of more than 900 educational activities, ASCP is the worldwide leader in providing CME/CMLE credit for the entire laboratory team.

Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)

The American Society for Clinical Pathology (ASCP), in collaboration with Pfizer Inc. and with participation from the American Society of Clinical Oncology (ASCO, invites proposals for pathology-centric Quality Improvement (QI) initiatives aimed at optimizing molecular testing pathways in the management of metastatic colorectal cancer (mCRC). This grant opportunity seeks to fund sustainable projects that improve biomarker testing practices, strengthen targeted therapy selection, and support care teams in implementing patient-centered protocols. 

The overarching goal of this program is to advance diagnostic excellence and improve treatment decision-making for patients with mCRC.

The American Academy of Otolaryngology–Head and Neck Surgery Foundation is inviting proposals for the CORE Funding: AHNS Presidential Award, aimed at enhancing value-based care in head and neck oncology. This initiative focuses on improving quality, efficiency, and patient outcomes through data-driven strategies. Key proposal components include quality and process measures, along with identifying care gaps. Priority areas include behavioral health integration and innovative contracting models, promoting scalable solutions that enhance care quality and value in this specialty.

National Collegiate Cancer Foundation

The National Collegiate Cancer Foundation (NCCF) is a national 501(c)(3) nonprofit organization dedicated to supporting young adults diagnosed with or impacted by cancer. Its mission is to provide services, resources, and need-based financial assistance that empower survivors and their families to adopt a resilient “Will Win” mindset throughout treatment and beyond. NCCF is one of the few national organizations that provides direct financial support to young adult cancer survivors, primarily through its Survivor and Legacy Scholarships, which assist students pursuing higher education during or after treatment. The Foundation also promotes cancer awareness and prevention within the young adult community. Recognizing that adolescents and young adults (ages 15–39) face unique challenges—including delayed diagnoses, limited access to insurance and clinical trials, fertility concerns, employment disruption, and social isolation—NCCF prioritizes addressing the significant service gaps affecting this underserved population. Operated entirely by volunteers, NCCF remains committed to advancing educational access, financial relief, and hope for young adult cancer survivors nationwide.

NCCF: Legacy Scholarship Program

The National Collegiate Cancer Foundation (NCCF) offers $1,000 competitive scholarships to young adults pursuing higher education who have lost a parent or guardian to cancer. The award is designed to provide financial assistance and encouragement to students continuing their education despite personal loss. Applications are evaluated based on the applicant’s personal journey, sources of encouragement, demonstrated financial need, notable accomplishments, and the quality of recommendations. The scholarship recognizes resilience, perseverance, and academic commitment in the face of cancer-related loss.

The NCI Pathway to Independence Award (K99/R00) aims to support talented postdoctoral researchers in their transition to independent faculty positions. This program provides essential NCI research funding to help awardees establish competitive, independent research careers. Applications must be submitted by 5:00 PM local time of the applicant's organization, ensuring timely consideration for this critical funding opportunity.

The ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant aims to enhance the research careers of residents and fellows focused on radiation oncology, specifically benefiting lung cancer patients. This initiative supports basic, translational, and clinical research endeavors. With a maximum award amount of $50,000 for one year, it provides essential funding to foster innovative projects that can lead to significant advancements in lung cancer treatment.

The Postdoctoral Grant Program at the University of Wisconsin School of Medicine and Public Health aims to support the growth and professional development of postdoctoral trainees, fellows, and associates. With funding up to $20,000 for one year, recipients can engage in independent research projects, attend workshops, or cover open-access publication fees. This initiative enhances research capacity and promotes health equity in Wisconsin, addressing critical health challenges while fostering career advancement in the medical field.